[Severe hypoprothrombinemia in a tubercular patient treated by combined rifampicin, isoniazid, streptomycin and prothionamide].
D000328:Adult; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007020:Hypoprothrombinemias / Q000139:chemically induced* / Q000188:drug therapy; D007538:Isoniazid / Q000627:therapeutic use*; D007539:Isonicotinic Acids / Q000627:therapeutic use*; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000150:complications*; D014813:Vitamin K Deficiency / Q000150:complications / Q000209:etiology
D007539:Isonicotinic Acids; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Hypoprothrombinémie sévère chez une malade tuberculeuse traitée par l'association rifampicine, isoniazide, streptomycine et prothionamide.